SOD1 and Dravet syndrome: Here, we introduce a new strategy for pleiotropic H2S oxidation and ROS dismutation using pleozymes, thereby harnessing SOD1’s cytoprotective benefits while mitigating its potentially toxic consequences for DS cells.